Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda

Simple item page
dc.contributor.authorBakanda, Celestin
dc.contributor.authorBirungi, Josephine
dc.contributor.authorMwesigwa, Robert
dc.contributor.authorNachega, Jean B.
dc.contributor.authorChan, Keith
dc.contributor.authorPalmer, Alexis
dc.contributor.authorFord, Nathan
dc.contributor.authorMills, Edward J.
dc.date.accessioned2022-02-04T11:48:00Z
dc.date.available2022-02-04T11:48:00Z
dc.date.issued2011
dc.description.abstractAdolescents have been identified as a high-risk group for poor adherence to and defaulting from combination antiretroviral therapy (cART) care. However, data on outcomes for adolescents on cART in resource-limited settings remain scarce. Methods: We developed an observational study of patients who started cART at The AIDS Service Organization (TASO) in Uganda between 2004 and 2009. Age was stratified into three groups: children (#10 years), adolescents (11–19 years), and adults ($20 years). Kaplan-Meier survival curves were generated to describe time to mortality and loss to follow-up, and Cox regression used to model associations between age and mortality and loss to follow-up. To address loss to follow up, we applied a weighted analysis that assumes 50% of lost patients had died. Findings: A total of 23,367 patients were included in this analysis, including 810 (3.5%) children, 575 (2.5%) adolescents, and 21 982 (94.0%) adults. A lower percentage of children (5.4%) died during their cART treatment compared to adolescents (8.5%) and adults (10%). After adjusting for confounding, other features predicted mortality than age alone. Mortality was higher among males (p,0.001), patients with a low initial CD4 cell count (p,0.001), patients with advanced WHO clinical disease stage (p,0.001), and shorter duration of time receiving cART (p,0.001). The crude mortality rate was lower for children (22.8 per 1000 person-years; 95% CI: 16.1, 29.5), than adolescents (36.5 per 1000 person-years; 95% CI: 26.3, 46.8) and adults (37.5 per 1000 person-years; 95% CI: 35.9, 39.1).en_US
dc.identifier.citationBakanda C, Birungi J, Mwesigwa R, Nachega JB, Chan K, et al. (2011) Survival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Uganda. PLoS ONE 6(4): e19261. doi:10.1371/journal.pone.0019261en_US
dc.identifier.other10.1371/journal.pone.0019261
dc.identifier.urihttps://nru.uncst.go.ug/xmlui/handle/123456789/1884
dc.language.isoenen_US
dc.publisherPLoS ONEen_US
dc.subjectHIV-Infected Adolescentsen_US
dc.subjectAntiretroviral Therapyen_US
dc.subjectUgandaen_US
dc.subjectNationally Representative Cohorten_US
dc.titleSurvival of HIV-Infected Adolescents on Antiretroviral Therapy in Uganda: Findings from a Nationally Representative Cohort in Ugandaen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Survival of HIV-Infected Adolescents on Antiretroviral.pdf
Size:
189.32 KB
Format:
Adobe Portable Document Format
Description:
Article
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Medical and Health Sciences